Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Company dossier
Cipla
NSE:CIPLA · ISIN INE059A01026
- Close
- ₹1,474.3 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Cipla
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Cipla Ltd - 500087 - Cipla Receives U.S. FDA Approval For Generic Advair Diskus®BSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Cipla LimitedNSE · conference call · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Copy of Newspaper Publication - Cipla LimitedNSE · financial results · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Cipla LimitedNSE · conference call · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,
2015BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,
2015BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Board Meeting Outcome for Outcome Of Board Meeting Dated 23Rd July 2026BSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Grant Of Stock Option And Employee Stock Appreciation RightsBSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Cipla LimitedNSE · financial results · pdf
Source filing Change in Management - Cipla LimitedNSE · exchange filing · pdf
Source filing Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Press Release - Cipla LimitedNSE · exchange filing · pdf
Source filing Investor Presentation - Cipla LimitedNSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Cipla LimitedNSE · financial results · pdf
Source filing Cipla Ltd - 500087 - Financial Results For Quarter Ended 30Th June, 2026BSE · financial results · pdf
Source filing General Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - USFDA Inspection At Invagen Manufacturing Facility In Central Islip, Long Island, NY, USABSE · exchange filing · pdf
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Cipla LimitedNSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing General Updates - Cipla LimitedNSE · esg rating · pdf
Source filing Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Cipla LimitedNSE · conference call · pdf
Source filing Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Archived filing Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Corrigendum To The Intimation Dated 3Rd July, 2026 Regarding 'Transcript Of The 90Th Annual General Meeting'BSE · exchange filing · pdf
Source filing Updates - Cipla LimitedNSE · exchange filing · pdf
Source filing Cipla Ltd - 500087 - Transcript Of The 90Th Annual General MeetingBSE · exchange filing · pdf
Source filing